<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Medicinova Inc. | Company News & Executive Profiles - MNOV | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/medicinova+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Medicinova Inc.]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[MediciNova Acquiring Avigen: A Post-Mortem]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F157846-medicinova-acquiring-avigen-a-post-mortem%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Greenbackd submits:  MediciNova Inc. (NASDAQ:MNOV) will acquire Avigen Inc (NASDAQ:AVGN) for $1.24 per share in cash or secured convertible notes. While the stock is trading at a slight premium to the bid, we&#8217;re taking the opportunity to exit. AVGN closed Friday at $1.29, which means we&#8217;re up 98.5% on...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 23 Aug 2009 11:38:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/greenbackd.html"><![CDATA[Greenbackd]]></category>
		<category domain="http://resources.bnet.com/topic/avigen+inc..html"><![CDATA[Avigen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/medicinova+inc..html"><![CDATA[Medicinova Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AVGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
		<category domain="tickers">AVGN,MNOV</category>
	</item>
	<item>
		<title><![CDATA[SCDE, UNRG, MNOV, NMCX Have Also Been Added To Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200612/ai_n19647226]]></link>
		<description><![CDATA[M2 PRESSWIRE-19 December 2006-BUYINS.NET: SCDE, UNRG, MNOV, NMCX  Have Also Been Added To Naked Short List TodayC1994-2006 M2  COMMUNICATIONS LTD    RDATE:19122006    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked short ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Dec 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/medicinova+inc..html"><![CDATA[Medicinova Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">MNOV,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[MediciNova, Inc. Acquires Phase II Anxiety Compound from Mitsubishi Pharma Corporation; Specialty Pharmaceutical Company Expands Product Portfolio]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_June_10/ai_n6061929]]></link>
		<description><![CDATA[Business Editors/Health/Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 10 Jun 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mitsubishi+pharma+corp..html"><![CDATA[Mitsubishi Pharma Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/medicinova+inc..html"><![CDATA[Medicinova Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
		<category domain="tickers">MNOV</category>
	</item>
	<item>
		<title><![CDATA[MediciNova to Present at the UBS Warburg Global Life Sciences Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Oct_2/ai_92349845]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  BIOWIRE2K  SAN DIEGO--BUSINESS WIRE--Oct. 2, 2002  MediciNova, Inc., a global, privately-held, specialty pharmaceutical company that develops therapeutic agents, announced today that its president and CEO, Takashi Kiyoizumi, M.D., Ph.D., will present at the UBS Warburg Global Life Sciences Conference, on Monday, October...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Oct 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agent.html"><![CDATA[agent]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/medicinova+inc..html"><![CDATA[Medicinova Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ubs+warburg.html"><![CDATA[UBS Warburg]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
		<category domain="tickers">MNOV</category>
	</item>
</channel>
</rss>
